p34cdc2 in invasive breast cancer:: relationship to DNA content, Ki67 index and c-erbB-2 expression

被引:0
|
作者
Wiesener, B
Hauser-Kronberger, CE
Zipperer, E
Dietze, O
Menzel, C
Hacker, GW
机构
[1] Gen Hosp, St Johanns Spital, Inst Pathol Anat, A-5020 Salzburg, Austria
[2] Gen Hosp, St Johanns Spital, Dept Gynecol & Obstet, A-5020 Salzburg, Austria
关键词
c-erbB-2; DNA ploidy; invasive mammary carcinoma; Ki67; p34(cdc2);
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: One-hundred and eighty-eight cases of human mammary carcinoma were examined immunohistochemically for their expression of Ki67, p34(cdc2) and c-erbB-2. DNA image cytometry was performed to evaluate DNA ploidy, Auer type, S-phase fraction (SPF), 5c exceeding rate (5cER) and 2c deviation index (2cDI). Methods and results: One-hundred and sixty-eight cases were invasive ductal carcinomas, 20 were of invasive lobular type. Routinely assessed oestrogen and progesterone receptor scores were available, The results were analysed statistically in comparison to tumour type, histopathological grade, lymph node status, menopausal status, patient age and overall survival. Ki67 (P<0.002) and c-erbB-2 (P<0.0001) correlated well with overall survival (P<0.0008) and grade (P<0.038) but not: with lymph node status and tumour type. p34cdc2 showed a trend towards a positive correlation with Ki67 (P<0.058) and a significant negative correlation with receptor status (P<0.008) but with none of the other parameters examined. Conclusions: No association between the DNA measured parameters (Auer type, SPF, 5cER and 2cDI) and survival was found. Our results suggest that c-erbB-2 and Ki67 are parameters which might, in combination with receptor status, help to define subgroups with different outcomes.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 50 条
  • [41] ATYPICAL ALVEOLAR HYPERPLASIA - RELATIONSHIP WITH PULMONARY ADENOCARCINOMA, P53, AND C-ERBB-2 EXPRESSION
    KERR, KM
    CAREY, FA
    KING, G
    LAMB, D
    JOURNAL OF PATHOLOGY, 1994, 174 (04) : 249 - 256
  • [42] SIGNIFICANCE OF IMMUNOHISTOCHEMICALLY DETECTED C-ERBB-2 PROTEIN EXPRESSION IN STAGE-III BREAST-CANCER, WITH REFERENCE TO NUCLEAR DEFORMITY, DNA CONTENT AND PROGNOSIS
    TAMURA, G
    MAESAWA, C
    MIKAWA, S
    SATODATE, R
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1991, 21 (04) : 264 - 267
  • [43] Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer
    Anderson, H.
    Hills, M.
    Zabaglo, L.
    A'Hern, R.
    Leary, A. F.
    Haynes, B. P.
    Smith, I. E.
    Dowsett, M.
    ANNALS OF ONCOLOGY, 2011, 22 (08) : 1770 - 1776
  • [44] A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer
    Ali, H. Raza
    Dawson, Sarah-Jane
    Blows, Fiona M.
    Provenzano, Elena
    Leung, Samuel
    Nielsen, Torsten
    Pharoah, Paul D.
    Caldas, Carlos
    JOURNAL OF PATHOLOGY, 2012, 226 (01) : 97 - 107
  • [45] C-ERBB-2 ONCOGENE RELATED TO P53 EXPRESSION, CELL-PROLIFERATION AND PROGNOSIS IN BREAST-CANCER
    JI, H
    LIPPONEN, P
    AALTOMAA, S
    SYRJANEN, S
    SYRJANEN, K
    ANTICANCER RESEARCH, 1993, 13 (04) : 1147 - 1152
  • [46] Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer
    Shun, CT
    Wu, MS
    Lin, JT
    Chen, SY
    Wang, HP
    Lee, WJ
    Wang, TH
    Chuang, SM
    HEPATO-GASTROENTEROLOGY, 1997, 44 (14) : 604 - 609
  • [47] UTERINE PAPILLARY SEROUS ADENOCARCINOMA - A 10-CASE STUDY OF P53 AND C-ERBB-2 EXPRESSION AND DNA CONTENT
    PRAT, J
    OLIVA, E
    LERMA, E
    VAQUERO, M
    MATIASGUIU, X
    CANCER, 1994, 74 (06) : 1778 - 1783
  • [48] Power Doppler breast ultrasound: association of vascularization and ER/c-erbB-2 co-expression in invasive breast carcinoma
    Chen, Shou-Tung
    Kuo, Shou-Jen
    Wu, Hwa-Koon
    Chen, Li-Sheng
    Chen, Dar-Ren
    BREAST CANCER, 2013, 20 (02) : 152 - 158
  • [49] Power Doppler breast ultrasound: association of vascularization and ER/c-erbB-2 co-expression in invasive breast carcinoma
    Shou-Tung Chen
    Shou-Jen Kuo
    Hwa-Koon Wu
    Li-Sheng Chen
    Dar-Ren Chen
    Breast Cancer, 2013, 20 : 152 - 158